Boldenone Undecylenate 200mg/ml 10x1ml Ampullen by Pharm-Tec

Usage

1. Confirm SARM selection and establish the intended weekly boldenone dose (150–250mg) before opening the first ampoule — calculate the number of ampoules required for the full cycle length.
2. Score and snap the ampoule at the marked break line using a sterile ampoule file; inspect the solution for cloudiness or particulate matter and discard any ampoule that does not appear clear and colourless.
3. Draw the calculated volume (e.g., 1.0ml for 200mg) into a sterile syringe using an 18-gauge draw needle, then switch to a 23–25 gauge, 1–1.5 inch injection needle for intramuscular administration.
4. Administer via intramuscular injection into the glute, vastus lateralis, or deltoid, rotating sites across the weekly split; aspirate before injecting and apply gentle pressure post-injection.
5. Take the daily SARM dose at a consistent time each day independently of injection timing; co-timing is not required as the two pharmacological classes operate on different administration schedules.
6. Log each injection date, volume, and injection site alongside daily SARM administration to maintain an accurate cycle record; submit a venous blood panel at Week 4 and Week 8 at minimum, capturing haematocrit, haemoglobin, LH/FSH, and lipids.

Warnings

Frequently asked questions

Can Pharm-Tec Boldenone Undecylenate 200mg/ml be used alongside SARMs in the same cycle?

Yes — boldenone undecylenate and SARMs operate through overlapping but non-identical pathways, making them complementary rather than redundant. Boldenone contributes erythropoietic stimulus and systemic androgen receptor activation while SARMs provide tissue-selective anabolic signalling. The combination allows practitioners to keep injectable androgen doses conservative — typically 150–250mg per week — while SARMs handle the lean-mass component.

Which SARMs are most frequently paired with injectable boldenone undecylenate?

LGD-4033 and RAD-140 are the most commonly reported pairings due to their strong anabolic potency in skeletal muscle tissue, allowing boldenone to fulfil a support and haematopoietic role rather than carrying the full anabolic workload. Ostarine is sometimes selected for milder cycles or recomposition phases where connective-tissue support alongside moderate lean-mass accrual is the primary goal.

What should athletes monitor specifically when running a SARM and boldenone undecylenate stack?

Haematocrit is the primary safety variable — boldenone stimulates erythropoietin production regardless of what SARMs are co-administered, and elevated red blood cell mass accumulates progressively across multi-week cycles. Blood lipid panels (HDL suppression), LH/FSH to assess HPG-axis suppression, and haemoglobin should all be assessed at six-to-eight-week intervals throughout the combined protocol via a standard venous blood draw.

Why does the 200mg/ml concentration offer a specific advantage in SARM combination cycles compared to higher-concentration boldenone products?

At 200mg/ml, weekly doses in the 150–250mg range — common when SARMs are covering part of the anabolic workload — translate to draw volumes of 0.75–1.25ml, which are comfortably measurable on standard syringes. Higher-concentration products require sub-0.5ml fractional draws for the same low-dose targets, increasing the likelihood of volumetric error and imprecise dosing.

What are the sterility advantages of the 10×1ml single-dose ampoule format during an extended SARM hybrid cycle?

Each ampoule is opened once and discarded after a single injection, eliminating the repeated needle-entry contamination risk associated with multi-dose vials used over 12–16 week SARM hybrid cycles. Glass ampoule seals confirm product integrity up to the point of use; any ampoule showing particulate matter, cloudiness, or a damaged seal should be discarded without use.

How should Pharm-Tec Boldenone Undecylenate 10x1ml ampoules be stored to maintain stability across a multi-week cycle?

Store ampoules at 15–25°C, away from direct light and moisture; opened ampoules must be used immediately and not stored. The sealed glass ampoule format preserves pharmaceutical stability without refrigeration under standard ambient storage conditions, making the 10-ampoule pack practical for a single extended cycle without quality degradation across the storage period. (2) angle_used

Manufacturer

Pharm-Tec entered the European injectable anabolic market with a clear positional choice: rather than manufacturing under its own GMP licence, the company built its commercial identity around rigorous inbound quality verification and cold-chain-controlled distribution of sourced finished preparations. The brand's history is one of curation over production — selecting suppliers whose batch documentation meets Pharm-Tec's own HPLC potency verification standard before any product is accepted into inventory. This approach means Pharm-Tec's catalogue is intentionally narrow: only preparations whose declared concentration can be independently confirmed via chromatographic analysis are stocked. The 10×1ml ampoule format adopted across the injectable line reflects a consistent product philosophy originating from the company's founding sourcing criteria — single-dose containers that arrive sealed, are verified by third-party HPLC, and require no further quality inference from the end user.